I
ndwelling central lines, such as peripherally inserted central catheters (PICCs), have become essential vascular devices, and the use of PICCs has recently been increasing among hospitalized and critically ill patients, as they provide prolonged vascular access for administering chemotherapy, dialysis, nutrition, and other diagnostics or medications (1) . Despite their use in lifesaving tasks, PICCs are also associated with central line-associated bloodstream infections (CLABSIs) (2-4) that extend hospitalization and increase costs and mortality rates (2, 5) . The rate of PICCrelated infections is 2.1 per 1,000 catheter-days among critically ill patients (4) . A recent meta-analysis on CLABSI with PICCs reported that PICC-associated CLABSIs occurred as frequently as with central venous catheters (CVCs) in hospitalized patient settings (6) . Recently, the CDC estimated that 18,000 CLABSIs occurred in intensive care units (ICUs) in the United States in 2009 alone, and 23,000 cases of CLABSI occur annually in patients outside ICUs (7) . Further, 37,000 CLABSIs occurred among patients receiving outpatient hemodialysis in 2008 alone (7) . At least 400,000 episodes of CLABSI occur every year among cancer patients alone (8) , and the overall annual cost estimates range from $296 million to $2.3 billion (9) (10) (11) .
In recently updated guidelines (3), the CDC recognized that catheters with antimicrobial coatings can play an important role in reducing device-associated infections in critical care patients, and they upgraded their recommendation for their use to its highest category (1A). Antimicrobial catheters coated with minocycline/rifampin (M/R) have been shown to reduce the risk of CLABSI (3) . Antimicrobial catheters treated with chlorhexidine and silver sulfadiazine (CHX/SS) reduced the rate of CLABSI in a randomized prospective clinical trial nearly 2 decades ago (12) , but in a more recent larger randomized prospective trial, these failed to significantly reduce the rates of CLABSI (13, 14) . More recently, a PICC treated with CHX only was introduced (15) ; however, no randomized prospective clinical trials have been performed to determine whether it reduces rates of CLABSI. In addition, in vitro studies have shown that commercially available M/R-and CHX-treated PICCs did not effectively reduce the risk of catheter colonization caused by Gram-negative bacteria, like Pseudomonas aeruginosa, and fungi, such as Candida species (16) . Therefore, the need remains for an antimicrobial-impregnated/ coated PICC that is effective against a wider spectrum of Gramnegative and fungal pathogens.
In order to meet this need, we developed a novel gendine (combination of gentian violet and chlorhexidine)-coated PICC and tested its antimicrobial efficacy and durability against highly pathogenic resistant pathogens from our hospital in a well-established biofilm colonization model (10), and we compared it to commercially available M/R-and CHX-treated PICCs. The biofilm colonization model is relevant, because microbial adherence on the surfaces of indwelling catheters leads to biofilm formation in a complex development process that involves distinct stages of primary adherence, cell-to-cell interaction, microcolony formation, and development of a mature biofilm (17) . Biofilms are extremely complex communities embedded in extracellular polymeric substances composed primarily of polysaccharides, proteins, and nucleic acids (18) , which retain nutrients for the constituent cells and defend them from the host immune response and antimicrobial agents (19) . As many as 60% of all microbial infections are related to biofilm formation (20) ; biofilms are clinically important, accounting for Ͼ80% of microbial infections in the body (21) . We also tested the gendine-coated catheter in vivo for acute biocompatibility in a rabbit intravascular model utilizing histopathological examination and pharmacokinetics of circulating antiseptic levels in the blood by liquid chromatography-mass spectrometry.
MATERIALS AND METHODS
Sequential coating of catheter with gendine. Gendine-coated PICCs were produced by applying a proprietary sequential treatment process to polyurethane PICCs following extrusion. This incorporated gendine into the catheter walls and the luminal and external surfaces. Gendine consisted of a mixture of gentian violet (Sigma-Aldrich, St. Louis, MO) and chlorhexidine (Sigma-Aldrich). Commercially available polyurethane PICCs, which were uncoated (nonantimicrobial), M/R treated (Spectrum; Cook Medical, Bloomington, IN), and CHX treated (Chloragϩard; Arrow International, Inc., Reading, PA) were included in the study as controls and comparators. Uncoated and gendine-coated PICCs were gamma sterilized at the MD Anderson Cancer Center Radiation facility, and the M/R-and CHX-treated PICCs were packaged sterile.
Testing the baseline antimicrobial efficacy of gendine-coated catheters by biofilm colonization. Uncoated control, M/R-treated, CHXtreated, and gendine-coated catheters were tested for the inhibition of biofilm formation using a biofilm colonization model (16, 22) . Segments (1-cm length) of uncoated control, M/R-treated, CHX-treated, and gendine-coated PICCs were tested for the inhibition of biofilm formation by methicillin-resistant Staphylococcus aureus (MRSA) strain MDACC4798, vancomycin-resistant enterococci (VRE) strain MDACC3238, P. aeruginosa strain MDACC4689, Escherichia coli strain MDACC2131, Acinetobacter baumannii strain MDACC2012, Enterobacter cloacae strain MDACC2265, Candida albicans strain MDACC009-3072, and Candida glabrata strain MDACC0786. These isolates were collected from infected patients at our hospital (MD Anderson Cancer Center [MDACC]). Triplicate PICC segments were first placed into sterile 24-well tissue culture plates containing 1 ml of human donor plasma to enhance the formation and binding of blood proteins and were incubated for 24 h at 37°C. Following incubation, the plasma was then replaced with Mueller-Hinton broth containing 5.0 ϫ 10 5 cells of various organisms and incubated for an additional 24 h. After incubation, the microbial inoculum was discarded, and segments were washed by shaking for 30 min in 1 ml of 0.9% sterile saline. The segments were then removed with sterile sticks, placed in 5 ml of 0.9% saline, and sonicated for 15 min. We also tested the catheter segments in 5 ml of Dey/Engley (D/E) neutralizing broth during the sonication process to halt any residual antiseptic activity (23, 24) . After sonication, each sample was vortexed for 5 s, and 100 l of liquid from each segment was serially diluted and spread onto Trypticase soy agar plus 5% sheep blood for quantitative culture of bacterial species (Sabouraud dextrose agar for yeast species). The plates were then incubated at 37°C, inverted for 24 h, and counted for colony growth. Our lower limit of detection was 5 colonies. The experiments were repeated twice (n ϭ 6 segments in total).
Durability of gendine-coated catheters in preventing biofilm colonization. To test the durability of inhibition of MRSA, VRE, P. aeruginosa, E. coli, A. baumannii, E. cloacae, K. pneumoniae, C. albicans, and C. glabrata biofilm formation, uncoated control, M/R-treated, CHX-treated, and gendine-coated PICC segments were challenged again after 1 week incubation in serum. The incubation was performed by immersing 6 segments of each PICC type in 10 ml of serum and incubating at 37°C for 1 week in order to simulate biological antimicrobial agent elution from an indwelling PICC. After 1 week, the segments were removed from the serum and tested for prolonged antimicrobial durability using a biofilm colonization model, as described above (16, 22) .
In vivo biocompatibility testing. The study was performed at the MD Anderson Cancer Center animal research facility. A rabbit in vivo model was employed, as described before (25) . Female New Zealand White rabbits (weight, 2.5 to 3.5 kg) were used after 1 week of acclimation. Surgery was performed aseptically in an operating room. After general anesthesia with 5% isoflurane, the rabbits were intubated and anesthetized with isoflurane (0.8 to 1.5%). Gamma-sterilized 5-French PICC catheters (length, approximately 6 in.) were inserted through a small incision over the right jugular groove of each rabbit, and subcutaneous tissue was bluntly dissected to expose the jugular vein. The jugular vein was isolated and surrounded with 3-0 silk suture. The vein was incised, and a catheter was inserted through the jugular vein and directed toward the heart. The incision was closed with surgical glue. The catheter was secured with surgical glue at the site of the venous incision and tacked to muscle to be secured. The remainder of the catheter was tunneled subcutaneously using a trocar to the dorsal scapular area, tacked to the underlying musculature, exteriorized through stab incision in the skin, ligated, and sutured under the skin.
The rabbits were divided in two groups (A and B). Group A contained three rabbits that had gendine-coated PICCs inserted into the jugular vein, and group B had two rabbits with uncoated control PICCs inserted into their jugular veins. We evaluated body weight loss, food and water intake, and temperature of the rabbits. Before the insertion of catheters, blood samples were collected from the ear vein at 0 h and used as controls. Blood samples were collected from the ear veins at 2, 24, 72, and 96 h postinsertion of catheters. Blood samples were centrifuged, plasma separated, and the samples were stored at Ϫ80°C until they were analyzed by liquid chromatography-mass spectrometry for levels of chlorhexidine and gentian violet.
Postmortem examination of rabbits and histopathology. The rabbits were sacrificed with an intravenous overdose of Beuthanasia, and complete necropsy was performed. The tissue samples were collected using a sterile surgical technique. Tissues from jugular veins and the subcutaneous tunnel to the dorsal scapular area were collected and placed in formalin and 5% glutaraldehyde. Three cross-sections of each submitted tissue were processed with paraffin, sectioned, stained with hematoxylin and eosin, and then examined histologically to assess toxicity and inflammatory infiltrate. Sections of tissues were examined by a pathologist blinded to the treatment group. The pathologist was blinded to the type of catheter used in each rabbit, and blinding was also employed for the individual collecting the tissue and blood samples. The severity of the inflammatory reaction was based on the quantification of inflammatory cells (neutrophils, lymphocytes, and plasma cells).
Liquid chromatography-mass spectrometry analysis of chlorhexidine and gentian violet. Chlorhexidine (CHX) and gentian violet (GV) were detected and quantified by liquid chromatography-tandem mass spectrometry (LC-MS/MS) using a Waters Xevo TQ-S triple quadrupole mass spectrometer coupled to a Waters Acquity ultraperformance liquid chromatography (UPLC) apparatus (Milford, MA) with temperaturecontrolled autosampler. The analytical column used to chromatographically resolve the compounds was a Phenomenex Kinetex phenyl-hexyl, 2.6-m particle size, 2.1 by 100-mm column (Torrance, CA). The chromatographic method used a linear gradient of (A) 0.1% formic acid in water and (B) 0.1% formic acid in acetonitrile starting at 5% B to 95% B in 4.75 min. The flow rate was maintained at 0.300 ml/min with a column temperature at 60°C. The total run time for the analysis was 10 min, with CHX having a retention time of 3.29 Ϯ 0.1 min and GV having a retention time of 4.53 Ϯ 0.1 min. The specific mass transitions used to detect and quantify were 253.2 to 170.0 and 372.2 to 356.4 for CHX and GV, respectively. The plasma samples were processed by protein precipitation using ice-cold acetonitrile to plasma at a 1:1 volume-to-volume ratio. The recovery of CHX and GV was Ͼ90%. An aliquot of the protein-depleted sample was then transferred to an LC sample vial for analysis by LC-MS/ MS. A high-performance liquid chromatography (HPLC) analytical scientist was blinded to the type of catheter used in each rabbit blood sample collected.
Statistical methods. Viable CFU recovered from biofilm colonization model tests were first compared using a Kruskal-Wallis test for each organism. If a significant result was detected for the test, we used Wilcoxon rank sum tests to compare the CFU between gendine-coated catheters versus each other type of catheters: M/R-treated, CHX-treated, and uncoated control. The ␣ levels of the post hoc pairwise comparisons were adjusted using Holm's sequential Bonferroni adjustment to control type I errors. For the durability of prolonged biofilm inhibition from baseline through week 1, two-way nonparametric analysis of variance (ANOVA) was used for comparing CFU among different types of catheters. All tests were two-sided, with a significance level of 0.05, except for the specific pairwise comparisons we made. Statistical analyses were performed using SAS version 9.3 (SAS Institute, Inc., Cary, NC).
RESULTS
Baseline efficacy of inhibition by gendine-coated catheters. After 24 h of microbial challenge, gendine-coated catheter segments completely prevented the formation of biofilms of MRSA, VRE, P. aeruginosa, E. coli, A. baumannii, E. cloacae, C. albicans, and C. glabrata and were significantly superior to uncoated control catheters, showing 5-to 7-log reductions in the number of viable biofilm colonies (P Ͻ 0.005). (Fig. 1, 2, and 3 ). In addition, the gendine-coated catheters showed better antimicrobial efficacy than M/R-treated catheters in the most species, except A. baumannii (P Յ 0. (Fig. 1) Fig. 1 to 3) . We found complete inhibition of biofilm formation of pathogens tested for both neutralizing and nonneutralizing broth.
Durability of inhibition by gendine-coated catheters. When we tested the durability of the prolonged inhibition of MRSA, VRE (Fig. 1), P. aeruginosa, E. coli, A. baumannii, E. cloacae (Fig.  2) , C. albicans, and C. glabrata (Fig. 3) biofilm formation, gendine-coated catheters completely inhibited biofilm growth of all pathogens tested after 1 week of incubation. The M/Rtreated, CHX-treated, and uncoated catheters permitted the growth of all organisms to various densities ( Fig. 1 to 3) . Data analysis showed that from baseline through week 1, gendine- Gram-positive bacteria. In vitro antimicrobial activity for 24 h (baseline) and durability from baseline through week 1 were tested by biofilm colonization method. Control, uncoated PICC; M/R PICC, minocycline/rifampin-treated PICC; CHX PICC, chlorhexidine-treated PICC. MRSA, methicillin-resistant S. aureus; VRE, vancomycin-resistant enterococci. *, significant differences in baseline efficacy compared to gendine-coated catheters (P ϭ 0.03); **, significant differences in baseline efficacy compared to gendine-coated catheters (P Ͻ 0.005). Gendine-coated catheters had a significantly different durability than that of the control (P Ͻ 0.0001), M/R-treated (P Ͻ 0.0001), and CHX-treated (P Յ 0.001) catheters. coated catheters had significantly better antimicrobial durability than that of the uncoated control catheters (P Ͻ 0.0001), M/R-treated catheters (P Ͻ 0.0001), and CHX-treated catheters (P Յ 0.001) (Fig. 1 to 3) .
Histopathology studies. A total of five rabbits were used for the histopathology study. Two rabbits received untreated control catheters, and three rabbits received gendine-treated catheters. Jugular veins and subcutaneous tissue through which a catheter
FIG 2 Antimicrobial efficacy and durability of M/R-treated, CHX-treated, and gendine-coated peripherally inserted central catheters (PICCs) tested against
Gram-negative bacteria. In vitro antimicrobial activity for 24 h (baseline) and durability from baseline through week 1 were tested by biofilm colonization method. Control, uncoated PICC; M/R PICC, minocycline/rifampin-treated PICC; CHX PICC, chlorhexidine-treated PICC. *, significant differences in baseline efficacy compared to gendine-coated catheters (P ϭ 0.03); **, significant differences in baseline efficacy compared to gendine-coated catheters (P Ͻ 0.005). Gendine-coated catheters had a significantly different durability than that of the control, M/R-treated, and CHX-treated catheters (P Ͻ 0.0001).
FIG 3 Antimicrobial efficacy and durability of M/R-treated, CHX-treated, and gendine-coated peripherally inserted central catheters (PICCs) tested against
fungi. In vitro antimicrobial activity for 24 h (baseline) and durability from baseline through week 1 were tested by biofilm colonization method. Control, uncoated PICC; M/R PICC, minocycline/rifampin-treated PICC; CHX PICC, chlorhexidine-treated PICC. *, significant differences in baseline efficacy compared to gendine-coated catheters (P ϭ 0.03); **, significant differences in baseline efficacy compared to gendine-coated catheters (P Ͻ 0.005). Gendine-coated catheters had a significantly different durability than that of the control, M/R-treated, and CHX-treated catheters (P Ͻ 0.0001).
had been tunneled were collected and analyzed from each rabbit. Three cross-sections of each submitted tissue were processed, sectioned, stained with hematoxylin and eosin, and examined histologically. The tissues were graded on the severity of tissue response for all sites (scale of minimal to marked responses). Rabbits with control (nonantimicrobial) catheters implanted exhibited mild to marked hyperplasia of myofibroblasts within the vessel wall (Fig.  4) . Rabbits with gendine-treated catheters exhibited a milder response (Fig. 5) . In all cases, the observed responses to the implant sites were clearly neither toxic nor traumatic in nature. The changes within the jugular vein were considered to be most likely to represent a response to the presence of the implanted catheters and not to the gendine coating. In conclusion, the rabbits with the control catheters exhibited more severe responses than those of the rabbits implanted with gendine-coated catheters.
Pharmacokinetics of chlorhexidine and gentian violet assessed by LC-MS. Chlorhexidine and gentian violet were detected without interfering peaks from plasma spiked with gentian violet and chlorhexidine standards and from plasma collected from rabbits with implanted gendine-coated catheters. The correlation curve was linear for the concentrations ranging from 0.05 ng/ml to 2.5 ng/ml, with correlation coefficients of 0.9937 and 0.9995 for chlorhexidine and gentian violet, respectively. The limit of detection was found to be 0.05 ng/ml for both chlorhexidine and gentian violet. The mean levels (n ϭ 3) of CHX were 0.91 ng/ml (at 2 h), 1.08 ng/ml (at 24 h), 0.41 ng/ml (at 72 h), and 0.29 ng/ml (at 96 h). No detectable levels of GV were found in any of the plasma samples (Table 1) .
DISCUSSION
Our data show that gendine-coated catheters are highly effective in preventing biofilm colonization of multidrug-resistant Grampositive and Gram-negative bacteria and fungi, including MRSA, VRE, P. aeruginosa, E. coli, A. baumannii, E. cloacae, C. albicans, and C. glabrata, compared to uncoated catheters (P Ͻ 0.0001). Furthermore, the gendine-coated catheters had greater antibiofilm activity and were significantly more effective than commercially available M/R-and CHX-treated catheters against most pathogens tested. The antimicrobial activity and durability of the gendine-coated catheters were also significantly superior to those of traditional M/R-and CHX-treated catheters in preventing biofilm colonization of various nosocomial pathogens tested after a week of immersion in serum.
Though M/R-treated CVCs have been associated with prolonged antimicrobial activity in vitro (26) , have excellent activity against multidrug-resistant staphylococci (27) , and performed well in completely preventing CLABSIs caused by staphylococci in large prospective randomized trials (26, 28, 29) , they failed to completely prevent CLABSIs caused by Gram-negative bacteria, like K. pneumoniae, E. cloacae, and Pseudomonas species (28) . The prevalence of Gram-negative bacterial CLABSIs increased from 14 to 19% of the CLABSI cases reported in 1986 to 1999 (30, 31) to 28% of the CLABSI cases reported in the last decade (32) . Furthermore, Candida species contribute up to 15% of all CLABSIs, and the attributable mortality rate of health care-associated candidemia has been reported to be between 38% and 49% (33) . Hence, our novel gendine-coated catheter promises to be useful in preventing Gram-negative bacterial CLABSIs and catheter-related infections caused by Gram-positive and fungi.
Gendine consists of gentian violet and chlorhexidine. Gentian violet is a triphenylmethane dye with antibacterial, antifungal, and antihelminthic activity. Gentian violet has been used topically ) were inserted through a small incision over the right jugular groove of each rabbit, and subcutaneous tissue was bluntly dissected to expose the jugular vein. The vein was incised, and an uncoated catheter was inserted through the jugular vein and directed toward the heart. The uncoated catheter was secured with surgical glue at the site to the venous incision and tacked to muscle to be secured. On day 4 (postmortem), all rabbits were manually restrained for mask induction of anesthesia with isoflurane. Three crosssections of each submitted tissue were processed with paraffin, sectioned, stained with hematoxylin and eosin, and examined histologically.
FIG 5
Histological cross-section of jugular vein of rabbit implanted with gendine-coated catheter. Gamma-sterilized 5-Fr. gendine-coated PICC catheters (length, approximately 6 in.) were inserted through a small incision over the right jugular groove of each rabbit, and subcutaneous tissue was bluntly dissected to expose the jugular vein. The vein was incised, and a gendinecoated catheter was inserted through the jugular vein and directed toward the heart. The gendine catheter was secured with surgical glue at the site to the venous incision and tacked to muscle to be secured. On day 4 (postmortem), all rabbits were manually restrained for mask induction of anesthesia with isoflurane. Three cross-sections of each submitted tissue were processed with paraffin, sectioned, stained with hematoxylin and eosin, and examined histologically.
throughout the world for many years, primarily to treat skin lesions coat the oral cavities of neonates, and as an oral rinsing agent for patients with oropharyngeal candidiasis (34) (35) (36) . Chlorhexidine is a cationic polybiguanide with antimicrobial activity and has also been used for a wide range of medical applications. A chlorhexidine-alcohol solution is used to disinfect skin surgical sites and as a hand scrub (37, 38) . Chlorhexidine has also been used to treat the umbilical cord of newborn babies (39) (40) (41) . Further, chlorhexidine has been used to impregnate latex gloves (42) . Among these two antimicrobial components of gendine, chlorhexidine increases the outer membrane permeability of pathogens and leads to leakage of their cellular contents (43) . Gentian violet induces cell penetration and DNA binding, which inhibits DNA replication through the production of hydroxyl/perhydroxy radicals (44, 45) . As they have independent mechanisms of action, we believe the increase in permeability produced by chlorhexidine works synergistically with gentian violet.
As an antiseptic combination not used for the treatment of systemic infections, gendine promises to be a more effective catheter treatment than those currently available and might reduce the risk of developing antibiotic-resistant pathogens. In addition, there are recent reports of pathogens that are increasingly resistant to chlorhexidine alone. Gram-negative bacteria, such as P. aeruginosa, A. baumannii, K. pneumoniae, and E. coli, are reported to be resistant to chlorhexidine (46) (47) (48) , and MRSA isolates with resistance to chlorhexidine have been found (48) . In addition, increases in the MICs for chlorhexidine have recently been reported for clinical isolates of A. baumannii (49) . Hence, the CHX PICC, which contains chlorhexidine only, presents a risk of being ineffective against those organisms resistant to chlorhexidine and further contributes to the development of chlorhexidine-resistant pathogens. In fact, the results of this study ( Fig. 2 and 3 ) highlight the limitations of the efficacy of the CHX PICC against multidrugresistant Gram-negative and fungal organisms. In contrast, not only did the gendine-coated PICC have significantly greater antimicrobial efficacy, but as a combination antiseptic treatment, the gendine-coated catheter is likely to have a low risk of developing increasingly chlorhexidine-resistant bacteria and fungi.
Our pharmacokinetics studies showed very low levels of chlorhexidine ranging from 0.29 ng/ml to 1.1 ng/ml over the 4-day period in our rabbit model. These levels of chlorhexidine were well below the level that was safely tolerated in other studies. The detectable median level of chlorhexidine in the blood was 32 ng/ml in 23 infants after 9 days of receiving umbilical cord disinfection with 1% chlorhexidine (50) . In a more recent study, among 27 blood samples collected from 12 chlorhexidine-exposed children, 23 (85%) had chlorhexidine levels up to 4.5 ng/ml, and 15% had up to 17 ng/ml (51) . Detectable levels of chlorhexidine have been reported in blood samples of 34 out of 96 patients, ranging from 10 ng/ml to 83 ng/ml, following vaginal washing with a 0.2% chlorhexidine solution (52) . In another study, 10 infants among 20 infants receiving 2% chlorhexidine antiseptics just prior to PICC placement (53) had detectable levels of chlorhexidine (1.6 to 206 ng/ml) in their serum. Since no detectable levels of gentian violet were found in the blood, we believe that chronic chlorhexidine exposure levels from the gendine-coated catheter might not be different from chronic chlorhexidine exposures with catheters.
Our current gendine-coated catheter study differs from a previous gendine-coated catheter study (22) in that antimicrobial testing was performed using a quantitative biofilm colonization model. Our team previously reported on the development of gendine-treated medical devices, such as CVCs, urinary catheters, endotracheal tubes, and gloves made of different types of polymers (22) (23) (24) 34) . These gendine-coated devices also showed antimicrobial efficacy and durability against a wide range of bacteria and fungi (22) (23) (24) 34) . Furthermore, gendine-impregnated urinary catheters were able to prevent urinary tract infections in a rabbit model (54) when challenged with E. coli.
Inflammatory changes vary slightly between uncoated control and gendine-coated catheters; however, no treatment-related effect can be discerned based upon the type and number of samples examined. With that said, the inflammatory and thrombotic changes observed in the control (untreated) catheters tended to exhibit increased severity compared to that of the gendine-coated catheters, although there were overlapping variations. Gentian violet has been reported in mammalian cells to inhibit NADPH oxidases, leading to NF-B inhibition and anti-inflammatory activity (55) , which might be a contributing factor.
No detectable levels of gentian violet were found in blood samples collected from rabbits, indicating that there is minimal to no accumulation or absorption of gentian violet in the blood. Gentian violet was reportedly used in hundreds of thousands of people a For the control rabbits, uncoated catheters were inserted in the jugular vein of the rabbit. Two rabbits were used for the control group. For the GEN-rabbits, gendine-coated catheters were inserted in the jugular vein of the rabbits. Three rabbits were used for the experimental group. Before insertion of the catheters, blood samples were collected at 0 h. The detection limit for chlorhexidine (CHX) and gentian violet (GV) was 0.5 pg/ml.
in South America (55) as a direct additive to blood to prevent the transmission of Chagas' disease at concentrations of 0.6 mM (Ͼ200,000 ng/ml) (45, 56) without major side effects and with reversible staining of patient tissues. A clinical trial studying the topical treatment of full-and partial-thickness wounds with 1% gentian violet in 70 geriatric patients found no adverse events related to gentian violet, and Ͼ90% of the wounds completely healed (57) . A recent review reports the clinical use of gentian violet at concentrations of Ն0.1% in complex dermatology patients and in the treatment of skin cancer (55) , and this was well tolerated with successful outcomes. This study has a number of limitations. First, the microbiologist in this study who conducted the biofilm colonization experiment on catheters was not blinded. Second, the focus of the study was to look at the acute toxicity to peak blood levels of chlorhexidine and gentian violet reached. We plan to study the effects of chronic toxicity on the prolonged implantation of catheters in the future.
Conclusions. Gendine-treated PICCs were very effective in preventing biofilm formation by a range of highly pathogenic Gram-positive and Gram-negative bacteria and fungi, and they were significantly superior to commercially available M/R-and CHX-treated PICCs. The pharmacokinetic testing established that acute systemic exposures of chlorhexidine and gentian violet from the gendine-coated catheters were either negligible, in the case of gentian violet, or well within safe levels, in the case of chlorhexidine. Furthermore, gendine-coated catheters were found to be biocompatible with a good safety profile in an intravascular setting and in tissues exhibited less severe implant responses than those with nonantimicrobial catheters, as assessed by histopathologic analysis in rabbits. In the future, larger animal studies would enable comparisons of statistical significance.
